Translate Bio to Present at Upcoming Investor Conferences
LEXINGTON, Mass, Feb. 19, 2020 (GLOBE NEWSWIRE) — Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing […]
Wingstop Inc. Reports Fiscal Fourth Quarter and Full Year 2019 Financial Results
DALLAS, Feb. 19, 2020 (GLOBE NEWSWIRE) — Wingstop Inc. (NASDAQ: WING) today announced financial results for the fiscal fourth quarter […]
WOW Unlimited Media Announces Board Changes
TORONTO and VANCOUVER, British Columbia, Feb. 19, 2020 (GLOBE NEWSWIRE) — WOW Unlimited Media Inc. (“WOW!” or the “Company”) (TSX-V: […]
Serengeti Receives METC Refund on Exploration Properties, Engages Corporate Communications Services and Grants Stock Options
VANCOUVER, British Columbia, Feb. 19, 2020 (GLOBE NEWSWIRE) — Serengeti Resources Inc. (SIR: TSX-V) announces that it is in receipt […]
Acreage Holdings Announces March 2020 Conference Attendance
NEW YORK, Feb. 19, 2020 (GLOBE NEWSWIRE) — Acreage Holdings, Inc. (“Acreage”) (CSE: ACRG.U) (OTCQX: ACRGF) (FSE: 0VZ), one of […]
NexTech Signs AR Deal With Steyr Arms USA
NEW YORK and TORONTO, Feb. 19, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), […]
Arcturus Therapeutics to Present at Two Investor Conferences in March
SAN DIEGO, Feb. 19, 2020 (GLOBE NEWSWIRE) — Arcturus Therapeutics (the “Company”, NASDAQ: ARCT), a leading messenger RNA medicines company […]
Crinetics Pharmaceuticals to Participate in SVB Leerink Global Healthcare Conference
SAN DIEGO, Feb. 19, 2020 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on […]
VIVUS Announces Commercial Launch of Qsymia® in the Republic of Korea Establishing New Royalty Revenue Stream
– VIVUS to Receive Milestone Payment from Alvogen; Significant Worldwide Growth Potential for Qsymia –CAMPBELL, Calif., Feb. 19, 2020 (GLOBE […]
Iterum Therapeutics to Present at the 9th Annual SVB Leerink Global Healthcare Conference
DUBLIN, Ireland and CHICAGO, Feb. 19, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company focused […]
